Virus causing respiratory tract illness in susceptible mammals
US-2016244850-A1 · Aug 25, 2016 · US
US9803252B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9803252-B2 |
| Application number | US-201715453764-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 8, 2017 |
| Priority date | Jan 19, 2001 |
| Publication date | Oct 31, 2017 |
| Grant date | Oct 31, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to the field of virology. The invention provides an isolated essentially mammalian negative-sense single-stranded RNA virus (MPV) within the subfamily Pneumovirinae of the family Paramyxoviridae and identifiable as phylogenetically corresponding to the genus Metapneumovirus and components thereof.
Opening claim text (preview).
What is claimed is: 1. A kit for determining the presence of metapneumovirus (MPV) in a mammalian subject, the kit comprising: a DNA probe of at least 10 nucleotides that specifically hybridizes to a target polynucleotide, wherein the target polynucleotide comprises a sequence encoding a polypeptide that is at least 90% identical to SEQ ID NO: 14 or the complement of the sequence, and wherein the DNA probe does not specifically hybridize to a polynucleotide from avian pneumovirus (APV). 2. The kit of claim 1 , wherein the DNA probe comprises at least 25 nucleotides. 3. The kit of claim 1 , wherein the DNA probe comprises at least 40 nucleotides. 4. The kit of claim 1 , wherein the DNA probe further comprises detectable marker. 5. The kit of claim 1 , wherein the target polynucleotide comprises a nucleic acid encoding SEQ ID NO: 14.
Immunostimulants · CPC title
for RNA viruses · CPC title
Drugs for disorders of the respiratory system · CPC title
Paramyxoviridae (F); Pneumoviridae (F), e.g. respiratory syncytial virus [RSV] · CPC title
from viruses · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.